Cabaletta Bio (CABA) Files Mixed Shelf

Go back to Cabaletta Bio (CABA) Files Mixed Shelf

Cabaletta Bio Inc. (CABA) PT Raised to $32 at Stifel

March 21, 2024 12:41 PM EDT

Stifel analyst Ben Burnett raised the price target on Cabaletta Bio Inc. (NASDAQ: CABA) to $32.00 (from $31.00) while maintaining a Buy rating.

The analyst comments "We like CABA's leading position in Myositis as this is a disease space where there isn't as much competition from... More